Conference Coverage
Conference Coverage
Older men with prostate cancer have greater risk of CVD, diabetes after prolonged hormonal therapy
Major Finding: The risks of cardiovascular disease and diabetes were elevated after more than 2 years of ADT among men in their mid-70s.Data...
Conference Coverage
New insights into aromatase inhibitor therapy nonpersistence
Major finding: Breast cancer patients with at least three of five self-reported symptoms prior to going on adjuvant aromatase inhibitor therapy...
Conference Coverage
Metastatic RCC patients taking common antihypertensives lived longer
Major Finding: Overall survival was 27 months among users of angiotensin system inhibitors and 17 months among nonusers (hazard ratio, 1.21; P = ....
Conference Coverage
Radiation therapy has long-term benefit in prostate cancer
Major finding: Addition of radiation therapy to lifelong antiandrogen therapy reduced 10-year prostate cancer–specific mortality from 19% to 8%....
Conference Coverage
Enzalutamide improves survival in chemo-naive metastatic prostate cancer
Major finding: Compared with placebo, enzalutamide yielded better overall survival (hazard ratio, 0.71) and radiographic progression-free survival...
Conference Coverage
Environmental stressors play major role in pediatric migraines
Conference Coverage
Aspirin didn’t extend survival in PIK3CA-mutant colorectal cancer
Major finding: With a median follow-up of 46 months, the 26% of the study population who were regular aspirin users and the non-users had...
Conference Coverage
Look beyond FDA for safe pregnancy prescribing
Conference Coverage
PCSK9 antibody shows safety, efficacy to 1 year
Major finding: Treatment with evolocumab every 4 weeks for 1 year safely cut average LDL cholesterol levels by 50%, compared with controls.Data...
Conference Coverage
Dual-vaccine therapy prolonged survival in pancreatic cancer
Major Finding: Compared with GVAX alone, GVAX followed by CRS-207 was associated with better overall survival (6.1 vs. 3.9 months; hazard ratio, 0...
Conference Coverage
CRT shown highly cost effective in mild heart failure
Major finding: Implantation of a cardiac resynchronization therapy device in patients with mild heart failure on optimal medical therapy had a...